Simin Guo

888 total citations · 1 hit paper
37 papers, 574 citations indexed

About

Simin Guo is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Simin Guo has authored 37 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 21 papers in Hepatology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Simin Guo's work include Hepatitis B Virus Studies (21 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis C virus research (16 papers). Simin Guo is often cited by papers focused on Hepatitis B Virus Studies (21 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis C virus research (16 papers). Simin Guo collaborates with scholars based in China, Australia and Netherlands. Simin Guo's co-authors include Shisan Bao, Honglian Gui, Qing Xie, Qing Guo, Hui Wang, Qing Xie, Wei Cai, Huijuan Zhou, Jianzhou Chen and Ziyan Wang and has published in prestigious journals such as Scientific Reports, The Journal of Infectious Diseases and Journal of Hepatology.

In The Last Decade

Simin Guo

35 papers receiving 562 citations

Hit Papers

Prognostic value of triglyceride glucose (TyG) index in p... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simin Guo China 13 387 280 105 67 66 37 574
Luciano Restivo Italy 7 491 1.3× 490 1.8× 56 0.5× 69 1.0× 51 0.8× 11 671
Ma Ai Thanda Han United States 10 481 1.2× 337 1.2× 62 0.6× 88 1.3× 25 0.4× 30 632
Tsutomu Tamai Japan 14 269 0.7× 172 0.6× 52 0.5× 94 1.4× 32 0.5× 37 508
Josephine H. Li United States 9 362 0.9× 419 1.5× 48 0.5× 62 0.9× 50 0.8× 20 573
Érika Rabelo Forte de Siqueira Brazil 8 235 0.6× 144 0.5× 37 0.4× 81 1.2× 35 0.5× 12 357
Keisuke Ojiro Japan 14 373 1.0× 293 1.0× 117 1.1× 59 0.9× 15 0.2× 30 653
Hiromi Kan Japan 16 317 0.8× 273 1.0× 36 0.3× 88 1.3× 21 0.3× 32 460
Yuqiang Mi China 11 356 0.9× 223 0.8× 20 0.2× 90 1.3× 41 0.6× 50 474
Yuta Wakui Japan 13 276 0.7× 199 0.7× 44 0.4× 47 0.7× 17 0.3× 23 467
Şafak Kızıltaş Türkiye 10 195 0.5× 95 0.3× 56 0.5× 69 1.0× 62 0.9× 28 381

Countries citing papers authored by Simin Guo

Since Specialization
Citations

This map shows the geographic impact of Simin Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simin Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simin Guo more than expected).

Fields of papers citing papers by Simin Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simin Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simin Guo. The network helps show where Simin Guo may publish in the future.

Co-authorship network of co-authors of Simin Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Simin Guo. A scholar is included among the top collaborators of Simin Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simin Guo. Simin Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yujiao, et al.. (2025). Lupus nephritis as an independent risk factor for carotid atherosclerosis in patients with systemic lupus erythematosus. Clinical Rheumatology. 44(5). 1927–1937. 1 indexed citations
3.
Guo, Simin, Yongjian Wang, Yiming Li, et al.. (2024). Synthesis and Anti-Liver Fibrosis Research of Aspartic Acid Derivatives. Molecules. 29(19). 4774–4774. 2 indexed citations
4.
Zhang, Na, Yiming Li, Simin Guo, et al.. (2024). Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway. Journal of Pharmaceutical Analysis. 15(3). 101048–101048. 2 indexed citations
5.
Guo, Simin, Yan Huang, Jingwen Feng, et al.. (2024). Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis. Hepatology International. 18(3). 892–903. 12 indexed citations
6.
Guo, Simin, et al.. (2024). Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV. Virology Journal. 21(1). 314–314. 5 indexed citations
7.
Guo, Simin, Yan Huang, Jie Xu, et al.. (2024). Interim analysis of the PARADISE study: Benefits of add-on peginterferon-α in NA-treated patients with CHB. Antiviral Research. 226. 105892–105892. 4 indexed citations
8.
Huang, Yan, et al.. (2022). qHBsAg for the Identification of Liver Histological Abnormalities in HBeAg-Negative Chronic Hepatitis B Patients with Normal and Mildly Elevated ALT Levels. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–7. 2 indexed citations
9.
Wang, Nan, Simin Guo, Fengjie Hao, et al.. (2022). Pseudogene SNRPFP1 derived long non-coding RNA facilitates hepatocellular carcinoma progress in vitro by sponging tumor-suppressive miR-126-5p. Scientific Reports. 12(1). 21867–21867. 2 indexed citations
10.
Huang, Yan, Rongtao Lai, Weijing Wang, et al.. (2022). Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. Frontiers in Cellular and Infection Microbiology. 11. 733348–733348. 14 indexed citations
11.
Wang, Lian, Simin Guo, Biyun Xu, et al.. (2022). Neuropathy scale score as an independent risk factor for myocardial infarction in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 38(7). e3561–e3561. 6 indexed citations
12.
Guo, Simin, Hong Huang, Yan Bi, et al.. (2021). Quantitative sensory testing can effectively predict cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus. Acta Diabetologica. 58(11). 1541–1549. 3 indexed citations
13.
Ren, Peipei, Hu Li, Yan Huang, et al.. (2021). A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China. Antiviral Research. 194. 105163–105163. 9 indexed citations
14.
Li, Chenxi, Yu Jin, Simin Guo, et al.. (2021). Better Islet Function and Cardiovascular Autonomic Function in Chinese Type 2 Diabetic Patients with Pure Small Fiber Neuropathy than with Mixed Neuropathy. Diabetes Therapy. 12(9). 2423–2436. 2 indexed citations
15.
Campenhout, Margo J. H. van, Willem Pieter Brouwer, Qing Xie, et al.. (2018). Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Journal of Viral Hepatitis. 26(1). 109–117. 14 indexed citations
17.
Lai, Rongtao, Xiaogang Xiang, Ruidong Mo, et al.. (2015). Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury. Journal of Hepatology. 63(1). 148–155. 47 indexed citations
18.
Lin, Lingnan, Vincent Wai‐Sun Wong, Huijuan Zhou, et al.. (2010). Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg‐negative patients. Journal of Medical Virology. 82(9). 1494–1500. 53 indexed citations
19.
Gui, Honglian, Haowei Wang, Yun Wu, et al.. (2010). Significant histopathology in Chinese chronic hepatitis B patients with persistently high–normal alanine aminotransferase. Journal of Viral Hepatitis. 17(s1). 44–50. 48 indexed citations
20.
Xie, Qing, Hui Wang, Honglian Gui, et al.. (2009). Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes and Infection. 11(4). 515–523. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026